Your browser doesn't support javascript.
loading
Acute and late toxicities in localized prostate cancer patients treated with low-dose 125I brachytherapy (110 Gy) in combination with external beam radiation therapy versus brachytherapy alone (160 Gy).
Mukai, Yuki; Hayashi, Narihiko; Koike, Izumi; Kaizu, Hisashi; Takano, Shoko; Sugiura, Madoka; Ito, Eiko; Sato, Mizuki; Uemura, Hiroji; Yao, Masahiro; Hata, Masaharu.
  • Mukai Y; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Hayashi N; Department of Urology, Yokohama City University Graduate School of Medicine.
  • Koike I; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Kaizu H; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Takano S; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Sugiura M; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Ito E; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Sato M; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
  • Uemura H; Department of Urology, Yokohama City University Medical Center, Yokohama, Japan.
  • Yao M; Department of Urology, Yokohama City University Graduate School of Medicine.
  • Hata M; Department of Radiation Oncology, Yokohama City University Graduate School of Medicine.
J Contemp Brachytherapy ; 10(5): 397-404, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30479615